Records containing: Hyperuricemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-06-22A Randomized Controlled Study of Kui-Yuan Chewable Tablets in the Treatment of Hyperuricemia
-
CLINICAL_TRIALS study record update · 2023-05-12A Phase 2b, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of AR882 Versus Placebo in Gout Patients
-
CLINICAL_TRIALS study record update · 2023-04-12A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled, Multicenter, Phase 2a Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 Monotherapy in Patients With Gout or Hyperuricemia
-
CLINICAL_TRIALS study record update · 2023-02-09ULTRA-T2D Study: Uric Acid Lowering Trial in Youth Onset T2D
-
CLINICAL_TRIALS study record update · 2023-01-23A Phase 1, Single Centre, Two-Part, Open Label, Crossover Study in Healthy Volunteers Using Scintigraphy to Characterize the In Vivo Performance of ALLN-346 Enteric Coated Tablets
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-08-16Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
-
CLINICAL_TRIALS study record update · 2022-08-01Pharmacogenetics of Sodium-dependent Glucose Transporter-2 (SGLT2) Inhibitors
-
CLINICAL_TRIALS study record update · 2022-07-25The Origin of Xanthine Oxidase and Its Metabolite, Uric Acid, in Preeclamptic Pregnant Women - A Pilot Study
-
CLINICAL_TRIALS study record update · 2022-02-18Assocaiton Between Uric Acid Trajecteries and Remission of Non-alcoholic Fatty Liver Disease (NAFLD) in NAFLD Individuals
-
CLINICAL_TRIALS study record update · 2022-02-14An Open Label Phase II Multiple Dose Safety, Pharmacokinetic and Pharmacodynamics Study of SEL-212 Followed by Open Label Administration of SEL-037 in Subjects With Symptomatic Gout and Elevated Blood Uric Acid
-
CLINICAL_TRIALS study record update · 2022-02-07A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
-
CLINICAL_TRIALS study record update · 2022-01-06A Single-Dose, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Way Crossover Study to Evaluate the Effect of LC350189 on the QTc (Corrected QT) Interval in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2022-01-06A Phase 1, Open-Label, Randomized, Single-Dose Crossover Study to Evaluate the Bioavailability of an LC350189 Tablet Relative to an LC350189 Capsule in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2021-11-05A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients With Hyperuricemia
-
CLINICAL_TRIALS study record update · 2021-07-23A Phase I Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
-
CLINICAL_TRIALS study record update · 2021-07-08Research on New Technologies for Diagnosis and Treatment of Skin Diseases and Venereal Diseases and Rheumatoid Diseases-- Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
-
CLINICAL_TRIALS study record update · 2021-07-01A Phase I Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
-
CLINICAL_TRIALS study record update · 2021-05-27Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2021-04-19Post-Authorisation Safety Study of Lesinurad
-
CLINICAL_TRIALS study record update · 2021-03-30Dietary Approaches to Stop Hypertension (DASH) Diet Effects on Serum Uric Acid (SUA) in Adults With Hyperuricemia and Gout
-
CLINICAL_TRIALS study record update · 2021-03-16Effect of Treatment of Hyperuricemia on Progression of Diabetic Nephropathy in Patients With Type II Diabetes Mellitus and Stage III Chronic Kidney Disease.
-
CLINICAL_TRIALS study record update · 2020-11-10Evaluation of the Effects of a Supplement Composed by Quercetin, Rutin, Bromelain and L-carnosine in Patients With Hyperuricemia, a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-10-22Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double-Blinded, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-10-14Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers (Single Center, Randomized, Open, 3 Cycles, 6 Sequences)
-
CLINICAL_TRIALS study record update · 2020-09-21A Phase 1, Open-Label, Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of LC350189 in Subjects With Varying Degrees of Renal Impairment